The company is focused on doing away with a problematic ingredient that many alt-meat startups rely on: fetal bovine serum. The serum comes from slaughtered cows, and it's used to grow animal cells for meat.
Meatable says it's avoiding serum by using a special type of stem cell that reproduces naturally. Those cells also present a challenge, however: they're notoriously hard to control. Meatable says it's using a proprietary technology created in partnership with two top-notch scientists from Cambridge who specialize in stem cell biology and neurosurgery to address the issue.
To become successful in the alt-meat market in 2030 and beyond, an early investment is required as supply chains, production facilities, and distribution channels must be built up and adapted to the new market requirements. Learn more:
If high cholesterol is derived from animal meat, is this going to lower LDL?